Add on dexmedetomidine in the treatment of severe alcohol withdrawal in a patient of emergency laparotomy

Roshan Madan Shende; Bhushan Mohanrao Ambare; Narendra Prabhakar Bachewar; Damodar Patwardhan

doi:10.18203/2320-6012.ijrms20150647

Authors

Roshan Madan Shende Department of Anesthesiology, SVNGMC, Yavatmal, Maharashtra
Bhushan Mohanrao Ambare Department of Anesthesiology, SVNGMC, Yavatmal, Maharashtra
Narendra Prabhakar Bachewar Department of Pharmacology, SVNGMC, Yavatmal, Maharashtra
Damodar Patwardhan Department of Anesthesiology, SVNGMC, Yavatmal, Maharashtra

DOI:

https://doi.org/10.18203/2320-6012.ijrms20150647

Keywords:

Alcoholic withdrawal syndrome, Delirium tremens, Dexmedetomidine, Emergency laparotomy

Abstract

According to American statistics 90% of people drink alcohol at some time in life. The estimated prevalence of alcohol abuse among hospitalized in patients is 20 % and 10- 33 % in patients admitted to the ICU. Approximately 18% of these patients will develop alcohol withdrawal syndrome (AWS) whose symptoms can include physical and psychological manifestations that range from mild to life threatening. Although AWS has been reported in literature in post-operative periods and in intensive care unit, there is less information on treatment and preparing of a patient with AWS, coming for emergency surgical procedure. The surgical stress and deranged liver functions possess an additional challenge to the anesthesiologist. Here we are reporting the successful management of a case of delirium tremens by using Dexmedetomidine in pre, intra and post-operative period in a patient with hollow viscous perforation for emergency laparotomy.

Metrics

Metrics Loading ...

References

Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995;333:1058-65.

Spies CD, Rommelspacher H. Alcohol withdrawal in the surgical patient: Prevention and treatment. Anesth Analg 1999;88:946-54.

Muzyk AJ, Fowler JA, Norwood DK, Chilipko A. Role of α2-agonists in the treatment of acute alcohol withdrawal. Ann Pharmacother. 2011;45(5): 649-657.

Carlson RW, Kumar NK, Wong-Mckinstry E, et al. Alcohol withdrawal syndrome. Crit Care Clin. 2012;28:549-595.

Sarff M, Gold JA. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med. 2010;38(9):S494-S501.

Imdahl H, Imdahl A. Prophylaxis and therapy of alcoholic delirium tremens in surgery: Analysis of questionnaire inquiry. Aktuelle Chir 1992;27:139-43.

Spies CD, Nordmann A, Brummer G, Marks C, Conrad C, Berger G, et al. Intensive care unit stay is prolonged in chronic alcoholic men following tumour resection of the upper digestive tract. Acta Anaesthesiol Scand 1996;40:649-56.

Rayner SG, Weinert CR, Peng H, Jepsen S, Broccard AF. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care. 2012;2(1):12.

DeMuro JP, Botros DG, Wirkowski E, Hanna AF. Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case series. J Anesth.2012;26:601-605.

Dailey RW, Leatherman JW, Sprenkle MD. Dexmedetomidine in the management of alcohol withdrawal and alcohol withdrawal delirium. Am J Respir Crit Care Med. 2011;183:A3164.

Al-Sanouri I, Dikin M, Soubani AO. Critical care aspects of alcohol abuse. South Med J. 2005;98:372–381.